Objectives 'Radiological intervention'to restore venous patency is the preferred therapy in
adults with Budd–Chiari syndrome (BCS). The published literature on pediatric BCS is …

This study was performed to evaluate the outcome of endovascular intervention therapy for
Budd-Chiari syndrome (BCS) and compare recanalization, transjugular intrahepatic …

Purpose To evaluate the long-term outcomes of percutaneous recanalization and determine
the predictors of patency and survival in a large case series of Chinese patients with Budd …

Abstract Background and Aim: Whether routine screening for the JAK2V617F mutation
should be performed in Chinese patients with Budd‐Chiari syndrome (BCS) and portal vein …

Medical treatment is regarded as the primary course of action in patients with Budd–Chiari
syndrome (BCS). Its efficacy, however, is limited, and most patients require interventional …

Objectives Budd–Chiari syndrome (BCS) is an uncommon cause of chronic liver disease in
children. The literature on the management of pediatric BCS is scarce. Our aim was to …

Management of clinically important sequelae of portal hypertension, such as variceal
bleeding and ascites, may involve a combination of medical, endoscopic, surgical, and …

Abstract Background Budd–Chiari syndrome (BCS) with hepatic vein (HV) occlusion is
manifested by severe liver damage in acute cases and esophageal variceal bleeding or …

This study aimed to evaluate the long-term efficacy and safety of percutaneous transhepatic
balloon angioplasty (PTBA) and transjugular intrahepatic portosystemic stent-shunt (TIPSS) …

Budd–Chiari syndrome (BCS) is a rare liver disease characterised by the obstruction of
draining hepatic veins, and subsequent reduced blood return to the heart. Although many …